239 related articles for article (PubMed ID: 37409224)
1. Prevalence and associated factors of metabolic-associated fatty liver disease in overweight Finnish children and adolescents.
Riekki H; Aitokari L; Kivelä L; Lahti S; Hiltunen P; Vuorela N; Huhtala H; Lakka TA; Kurppa K
Front Endocrinol (Lausanne); 2023; 14():1090344. PubMed ID: 37409224
[TBL] [Abstract][Full Text] [Related]
2. Updated upper limits of normal serum alanine aminotrasferase levels for screening metabolic dysfunction-associated fatty liver disease in obese children.
Lin YC; Chang PF; Ni YH
J Formos Med Assoc; 2022 Dec; 121(12):2548-2555. PubMed ID: 35738972
[TBL] [Abstract][Full Text] [Related]
3. Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease.
Wu T; Ye J; Shao C; Li F; Lin Y; Ma Q; Wang W; Feng S; Zhong B
Front Endocrinol (Lausanne); 2021; 12():691556. PubMed ID: 34899591
[TBL] [Abstract][Full Text] [Related]
4. Maternal gestational hypertension, smoking and pre-eclampsia are associated with metabolic dysfunction-associated fatty liver disease in overweight offspring.
de Ruyter H; Aitokari L; Lahti S; Riekki H; Huhtala H; Lakka T; Laivuori H; Kurppa K
Acta Obstet Gynecol Scand; 2024 Jun; 103(6):1183-1191. PubMed ID: 38433535
[TBL] [Abstract][Full Text] [Related]
5. Triglyceride glucose index, pediatric NAFLD fibrosis index, and triglyceride-to-high-density lipoprotein cholesterol ratio are the most predictive markers of the metabolically unhealthy phenotype in overweight/obese adolescent boys.
Furdela V; Pavlyshyn H; Shulhai AM; Kozak K; Furdela M
Front Endocrinol (Lausanne); 2023; 14():1124019. PubMed ID: 37234798
[TBL] [Abstract][Full Text] [Related]
6. Association between the non-HDL-cholesterol to HDL-cholesterol ratio and non-alcoholic fatty liver disease in Chinese children and adolescents: a large single-center cross-sectional study.
Yang S; Zhong J; Ye M; Miao L; Lu G; Xu C; Xue Z; Zhou X
Lipids Health Dis; 2020 Nov; 19(1):242. PubMed ID: 33222696
[TBL] [Abstract][Full Text] [Related]
7. Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults.
Liu J; Ayada I; Zhang X; Wang L; Li Y; Wen T; Ma Z; Bruno MJ; de Knegt RJ; Cao W; Peppelenbosch MP; Ghanbari M; Li Z; Pan Q
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e573-e582. PubMed ID: 33618024
[TBL] [Abstract][Full Text] [Related]
8. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095
[TBL] [Abstract][Full Text] [Related]
9. Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Children and Adolescents: Systematic Review and Meta-Analysis.
Liu J; Mu C; Li K; Luo H; Liu Y; Li Z
Int J Public Health; 2021; 66():1604371. PubMed ID: 34690666
[No Abstract] [Full Text] [Related]
10. Metabolic dysfunction-associated fatty liver disease in people living with HIV.
Michel M; Labenz C; Armandi A; Kaps L; Kremer WM; Galle PR; Grimm D; Sprinzl M; Schattenberg JM
Sci Rep; 2023 Jun; 13(1):9158. PubMed ID: 37280241
[TBL] [Abstract][Full Text] [Related]
11. Alanine aminotransferase cutoffs for the pediatric fatty liver disease: Major impact of the reference population.
Aitokari L; Lahti S; Kivelä L; Riekki H; Hiltunen P; Vuorela N; Viitasalo A; Soininen S; Huhtala H; Lakka T; Kurppa K
J Pediatr Gastroenterol Nutr; 2024 Mar; 78(3):488-496. PubMed ID: 38314943
[TBL] [Abstract][Full Text] [Related]
12. The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children.
El-Koofy NM; Anwar GM; El-Raziky MS; El-Hennawy AM; El-Mougy FM; El-Karaksy HM; Hassanin FM; Helmy HM
Saudi J Gastroenterol; 2012; 18(1):44-9. PubMed ID: 22249092
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.
Wang X; Wu S; Yuan X; Chen S; Fu Q; Sun Y; Lan Y; Hu S; Wang Y; Lu Y; Qu S; Wang L
J Clin Endocrinol Metab; 2022 Jan; 107(2):e745-e755. PubMed ID: 34467980
[TBL] [Abstract][Full Text] [Related]
14. Gender-specific differences in clinical and metabolic variables associated with NAFLD in a Mexican pediatric population.
Villanueva-Ortega E; Garcés-Hernández MJ; Herrera-Rosas A; López-Alvarenga JC; Laresgoiti-Servitje E; Escobedo G; Queipo G; Cuevas-Covarrubias S; Garibay-Nieto GN
Ann Hepatol; 2019; 18(5):693-700. PubMed ID: 31151875
[TBL] [Abstract][Full Text] [Related]
15. Obese boys at increased risk for nonalcoholic liver disease: evaluation of 16,390 overweight or obese children and adolescents.
Wiegand S; Keller KM; Röbl M; L'Allemand D; Reinehr T; Widhalm K; Holl RW;
Int J Obes (Lond); 2010 Oct; 34(10):1468-74. PubMed ID: 20531349
[TBL] [Abstract][Full Text] [Related]
16. New predictive models and indices for screening MAFLD in school-aged overweight/obese children.
Xing Y; Zhang P; Li X; Jin S; Xu M; Jia J; Wang HJ; Li L; Wang H
Eur J Pediatr; 2023 Nov; 182(11):5025-5036. PubMed ID: 37648793
[TBL] [Abstract][Full Text] [Related]
17. [Metabolic syndrome in overweight and obese schoolchildren in Beijing].
Wan NJ; Mi J; Wang TY; Duan JL; Li M; Gong CX; Du JB; Zhao XY; Cheng H; Hou DQ; Wang L
Zhonghua Er Ke Za Zhi; 2007 Jun; 45(6):417-21. PubMed ID: 17880785
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and Risk Factors of Metabolic Dysfunction-Associated Fatty Liver Disease with Renal Insufficiency in Overweight/Obese Adults.
Shi A; Deng J; Ma J; Yang L; Tantai X; Wang Q; Chang D; Wang J; Guo X; Lu X; Shi H
Obes Facts; 2023; 16(6):548-558. PubMed ID: 37640023
[TBL] [Abstract][Full Text] [Related]
19. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
Yi M; Chen RP; Yang R; Chen H
Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
[TBL] [Abstract][Full Text] [Related]
20. Metabolic (Dysfunction)-Associated Fatty Liver Disease in Chinese Patients with Type 2 Diabetes from a Subcenter of the National Metabolic Management Center.
Guan C; Fu S; Zhen D; Yang K; An J; Wang Y; Ma C; Jiang N; Zhao N; Liu J; Yang F; Tang X
J Diabetes Res; 2022; 2022():8429847. PubMed ID: 35127953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
